Performance characteristics of laboratory testing and clinical outcomes

Area of Science:

• Clinical Chemistry
• Laboratory Medicine
• Medical Diagnostics

Background:

• Diabetes mellitus serves as a model disease for evaluating laboratory test performance and its link to clinical outcomes.
• Laboratory tests are crucial for diabetes diagnosis, monitoring treatment efficacy, and assessing prognosis.

Purpose of the Study:

• To demonstrate the relationship between laboratory test performance characteristics and clinical outcomes in diabetes.
• To critically evaluate the current state-of-the-art methodologies for key laboratory tests used in diabetes care.
• To discuss the impact of analytical interferences on test results and clinical decision-making.

Main Methods:

• Review of established laboratory tests for diabetes: glucose (diagnosis), creatinine (renal function), and cardiac troponins (cardiovascular assessment).
• Analysis of current methodological limitations and criticisms in laboratory testing.
• Examination of analytical interferences, specifically macroprolactin and heterophilic antibodies.

Main Results:

• Glucose, creatinine, and cardiac troponin assays are fundamental in diabetes management but face methodological challenges.
• Analytical interferences, such as macroprolactin and heterophilic antibodies, can lead to unexpected and erroneous results.
• Undisclosed factors contributing to interferences can significantly impact patient diagnosis and treatment.

Conclusions:

• The performance of laboratory tests is critical for effective diabetes care, from diagnosis to prognosis.
• Addressing analytical interferences is essential to ensure the reliability of laboratory results and prevent adverse clinical outcomes.
• Further research into mitigating interferences from factors like macroprolactin and heterophilic antibodies is warranted.